Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are DescribedGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingNot stated2026-08-06NCT04122976

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bayer178

40 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Advanced Urology InstituteDaytona BeachUnited States10
Arizona Institute of UrologyTucsonUnited States2
Associated Medical Professional UrologySyracuseUnited States1
Associated Urologists of NCRaleighUnited States2
Baylor Scott & White Medical Center - TempleTempleUnited States13
Beacon Cancer CareBeaconUnited States1
First Urology, PSCJeffersonvilleUnited States8
Genesis Comprehensive Prostate Cancer CenterSan DiegoUnited States1
Integrated Medical Professionals, PLLCNorth New Hyde ParkUnited States1
Keystone Urology SpecialistsLancasterUnited States6
Manatee Medical Research InstituteBradentonUnited States2
Many locationsMultiple LocationsGreece6
Many locationsMultiple LocationsArgentina4
Many LocationsMultiple LocationsItaly8
Many LocationsMultiple LocationsBelgium5
Many LocationsMultiple LocationsSpain9
Many locationsMultiple LocationsRussia1
Many locationsMultiple LocationsJapan10
Many LocationsMultiple LocationsAustria3
Many locationsMultiple LocationsCanada4
Many locationsMultiple LocationsTaiwan5
Many LocationsMultiple LocationsDenmark5
Many locationsMultiple LocationsChina4
Many locationsMultiple LocationsBrazil4
Many locationsMultiple LocationsColombia4